Behavioral Interventions for Cardiovascular Disease
(BETTER P2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve recruitment of Black and Hispanic individuals for heart disease studies. Researchers are testing various invitation methods, such as messages that emphasize helping others, offer incentives, or highlight the prevalence of the condition. They seek to determine which methods increase participation in clinical trials. Individuals with heart disease who receive treatment at clinics with active medical records may be suitable candidates. As an unphased study, this trial provides a unique opportunity to contribute to research that could enhance recruitment strategies and increase diversity in clinical trials.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that these recruitment strategies are safe for increasing trial enrollment?
Research has shown that using various communication methods and incentives to encourage clinical trial participation is generally safe. No evidence suggests that recruitment methods cause harm.
For example, studies on message framing—such as appealing to altruism or highlighting others' participation—examine their influence on behavior without reporting safety concerns. Similarly, offering small financial rewards or lottery entries has been studied for effectiveness in encouraging participation, with no mention of safety risks.
Since this trial tests recruitment strategies rather than a new medical treatment, it involves no physical risks. The trial is in the "Not Applicable" phase, focusing on strategies rather than drug safety. Therefore, participation in this type of study is considered low-risk.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different behavioral strategies can boost participation in cardiovascular research. Unlike typical treatments that focus on medication or surgery, this trial looks at communication techniques like appealing to altruism, using social proof, or offering incentives to see what encourages more people to join studies. By experimenting with different messaging and contact methods, researchers aim to discover the most effective ways to engage potential participants, which could lead to better representation and more robust data in future cardiovascular studies.
What evidence suggests that this trial's recruitment strategies could be effective for increasing enrollment of Black and Hispanic participants in heart disease clinical trials?
Research shows that different ways of presenting messages can encourage more people to join clinical trials. In this trial, participants will be randomized into different arms to test these strategies. One arm will use the Framing Method, appealing to altruism, which encourages helping others and can increase participation. Another arm will use social proof, highlighting that others like the participant are joining, a method proven effective in marketing studies. Additionally, some arms will offer financial incentives, such as small guaranteed payments or chances to win larger amounts, to motivate participation. The method of contact, such as receiving messages from personal clinics or research teams, will also be tested for its effect on response rates. These strategies have been studied and show promise in increasing participation, especially among under-represented groups, in important health studies.12467
Are You a Good Fit for This Trial?
This trial is for Black and Hispanic individuals with active medical records at the participating site. It aims to improve diversity in cardiovascular disease studies by testing different recruitment strategies.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Recruitment Strategy Testing
Testing different recruitment strategies to increase enrollment of Black and Hispanic individuals in cardiovascular cohort studies
Follow-up
Participants are monitored for enrollment outcomes and trust in medical researchers
What Are the Treatments Tested in This Trial?
Interventions
- Framing Method (Appeal to Altruism)
- Framing Method (Opt-Out)
- Framing Method (Social Proof or Perceived Scarcity)
- Incentive Structure
- Method of Contact
- Source of Contact
Trial Overview
The study tests various methods to boost enrollment of under-represented groups in heart disease trials, including incentive structures, message framing (like social proof or scarcity), opt-out options, contact methods, and appeals to altruism.
How Is the Trial Designed?
13
Treatment groups
Active Control
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the person's personal clinic.
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include language about social proof, i.e. information about participation of individuals similar to the person being contacted. For example, the message will include language such as: "Clinical research studies and the development of effective new medications would not have been possible without the participation of thousands of people like you".
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include no language about appeal to altruism or social proof.
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will have no language about incentives.
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $25.
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $15 and have a 1 in 20 chance to receive $200.
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 20 chance to receive $500.
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 100 chance to receive $2500.
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the research team.
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will appeal to the person's altruism, for example: "Research studies like this one often do not include enough Black individuals. If Black people are not included in research like this, then doctors have less information about how cardiovascular disease might affect them and how new treatments could be used to improve their health. Your participation in this research can help doctors better understand how to treat members of your community in the future."
Potential participants in the parent trial will be randomized to receive a message via text message. This message will invite them to participate in the parent trial.
Potential participants in the parent trial will be randomized to receive a message via email. This message will invite them to participate in the parent trial.
Potential participants in the parent trial will be randomized to receive a message via email and text message. This message will invite them to participate in the parent trial.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
American Heart Association
Collaborator
Emory University
Collaborator
Published Research Related to This Trial
Citations
Testing Promising Behavioral Economic Interventions to ...
Marketing studies have demonstrated the effectiveness of appeals to altruism, perceived scarcity ("This product is desirable because it is hard to get"), and ...
A series of randomized trials of behavioral economic ...
A series of randomized trials of behavioral economic interventions to increase racial and ethnic diversity of research participants: Rationale ...
Behavioral Interventions for Cardiovascular Disease ...
The BETTER P2 medical study, being run by University of Pennsylvania, needs participants to evaluate whether Framing Method (Appeal to Altruism), ...
Framing financial incentives to promote hypertension care ...
This study will determine the effectiveness of a 6-month framing financial incentive intervention in improving doctors' hypertension management.
Impact of technology-based patient education on ...
Objective To collect evidence on what types of technology and content are most effective in helping people with coronary heart disease (CHD) to change their ...
Effects of message framing and risk perception on health ...
The pilot study aims to elucidate the most effective risk communication strategy, utilizing message framing (gain-framed, loss-framed, or no-framed), for ...
7.
researchgate.net
researchgate.net/publication/303086438_Rethinking_Risk_Prospect_Theory_Application_in_Health_Message_Framing_ResearchProspect Theory Application in Health Message Framing ...
This study reports the results of two experiments designed to explore these alternative conceptualizations of risk and their effect on health decision making.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.